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abstract
Iron deficiency is the most common mammalian nutritional deficiency during the neonatal pe-
riod. However, among mammalian species neonatal iron deficiency anemia (IDA), the most severe 
consequence of iron scarcity, occurs regularly in pigs. Although intramuscular supplementation 
of piglets with high amounts of iron dextran (FeDex) is largely considered an appropriate pre-
ventive therapy for IDA prophylaxis, an increasing evidence shows that it negatively affects pig 
physiology. The aim of our study was to evaluate the efficacy of non-invasive supplementation of 
piglets with sucrosomial ferric pyrophosphate (SFP), a highly bioavailable dietary iron supple-
ment in preventing IDA, in humans and mice. Results of our study show that SFP given to piglets 
per os in the amount of 6 mg Fe daily efficiently counteracts IDA at a rate comparable with the 
traditional FeDex-based supplementation (100 mgFe/kG b.w.; i.m. injection). This was indicated 
by physiological values of red blood cell indices and plasma iron parameters measured in 28-day-
old piglets. Moreover, SFP-supplemented piglets showed significantly lower (P≤0.05) plasma level 
of 8-isoprostane, a biomarker for oxidative stress compared to FeDex-treated animals, implying 
lesser toxicity of this order of iron replenishment. Finally, supplementation with SFP does not 
increase considerably the blood plasma hepcidin, a peptide that acts to inhibit iron absorption 
from the diet. SFP emerges as a promising nutritional iron supplement, with a high potential to be 
adopted in the postnatal period.
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Iron deficiency anemia (IDA) is the most prevalent micronutrient deficiency 
disorder in suckling piglets of high performance pig (Sus scrofa domestica) breeds 
(Svoboda and Drabek, 2005; Kim et al., 2018; Szudzik et al., 2018). Selective breed-
ing of domestic pigs has been used to control desirable reproduction and growth 
traits of newborn piglets for centuries (Rubin et al., 2012). It seems, therefore, that 
both high litter size and daily gain in body weight (connected with the increase in 
blood volume and number of red blood cells) delineate in piglets an unattainable 
physiological standard for iron demands and thus are among major etiological fac-
tors in pig IDA (Svoboda and Drabek, 2005; Rincker et al., 2005; Kim et al., 2018; 
Szudzik et al., 2018). Early supplementation of iron to piglets (on days 3–6 postpar-
tum) by the intramuscular injection of large amounts (100 Fe mg/kg b.w or 200 mg 
Fe per piglet on day 3 after birth) of iron dextran (FeDex) is the most frequent way 
to prevent the development of IDA in piglets (Egeli and Framstadt, 1999). Although 
this treatment has an undeniable potential to sustain iron balance and provide suf-
ficient amount of this microelement for erythropoietic needs, it may induce harmful 
reactive oxygen species. It may also incidentally induce sudden cardiovascular col-
lapse and respiratory failure, caused by fatal anaphylaxis leading to asphyxia and 
hypotension (Ueberschär, 1966). Alternatively, oral iron supplementation in piglets 
with iron salts and chelates seems to be relatively inefficient (Szabo and Bilkei, 
2002; Egeli and Framstad, 1998; Svoboda and Píštková, 2018) except when applied 
in very high amounts (Maes et al. 2011), mainly because inorganic iron displays low 
bioavailability and molecular mechanisms of iron absorption in newborn animals are 
immature (Lipiński et al., 2010). 
Sucrosomial® iron is an innovative sucrosomial ferric pyrophosphate (SFP) sup-
plement containing phospholipids and sucrose esters of fatty acids assuring its high 
bioavailability and tolerability (Pisani et al., 2015; Gómez-Ramírez et al., 2018). The 
efficacy of SFP in correcting iron deficiency attested by the restoration of physiologi-
cal hemoglobin levels has been proven in human and animal studies (Giordano et al., 
2015; Parisi et al., 2017). Here, we show that SFP given orally to suckling piglets is 
a suitable feed additive for the reinforcement of iron status in piglets in the critical 
period from birth to weaning. Compared to parental FeDex, oral supplementation 
with SFP is not only as effective but also resulted in lower levels of the oxidative 
stress biomarker 8-isoprostane. To our knowledge, this study provides first dem-
onstration of successful preventive/therapeutic use of SFP in mammalian neonates. 
This suggests that iron contained in SFP can be efficiently transported across the 
intestinal barrier and become bioavailable despite immaturity of molecular mecha-
nisms of iron absorption due to its specific chemical formula.
Material and methods
Ethic statement
The experimental procedures used in this study were in compliance with the EU 
guidelines for the care and handling of research animals (EU Directive 2010/63/EU 
for animal experiments). The Second Local Ethical Committee on Animal Testing at 
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the Warsaw University of Life Sciences in Warsaw granted a formal waiver of the 
ethical approval because the only procedure involved in the study was euthanasia 
and intramuscular injection of FeDex to piglets is a routine veterinary procedure. 
Moreover, administration of a dietary supplement such as sucrosomial ferric pyroph-
osphate is not considered a research procedure.
Piglets, experimental design and biological sample collection
Experiment was conducted at the Pig Hybridization Centre in Pawłowice be-
longing to the National Research Institute of Animal Production (Balice, Poland). 
A total of 18 Polish Landrace piglets (males) from 6 different litters housed in stand-
ard conditions (70% humidity and a temperature of 22°C in cages with straw bed-
ding) were used. During the experiment sows were allowed to nurse their piglets and 
piglets had no access to the sows’ feed. The Prestarter Wigor 1 Plus feed (containing 
238 mg Fe per 1 kg as estimated by flame air-acetylene AAS using PerkinElmer Life 
Sciences 1100B, MA, USA instrument at 248.3 nm) was offered to piglets from day 
5 to day 28 after birth. The composition and nutritive value of Prestarter Wigor 1 Plus 
is shown in Supplementary Table 1. Piglets from 6 different litters were randomly 
allotted to 2 experimental groups on the basis of balanced body weight and equal-
ized red blood cell indices at day 3 after birth. Each litter provided piglets for two 
experimental groups. Other piglets from the litter not selected for experiment did 
not participate in them but remained with their mothers. First group of piglets (n=9; 
FeDex) received parenteral iron supplementation (Ferran®100, Vet-Agro, Lublin, 
Poland, Fe3+100 mg/ml; 100 Fe mg/kg BW) on the third day of life, by intramuscular 
injections of FeDex in the neck. This routinely applied iron supplement is a com-
plex of ferric ions with low molecular weight dextran. The second group of piglets 
(n=9; SFP) received oral iron supplementation (Sucrosomial® iron; (PharmaNutra, 
Pisa, Italy, Ingredients: Ferro Sucrosomiale® (iron pyrophosphate – 6 mg of Fe/g of 
powder, pregelatinised rice starch, saccharic esters of fatty acids, sunflower lecithin 
supported on glucose syrup, milk proteins, tricalcium phosphate) in a daily dose of 
6 mg/kg BW from day 5 to 28 of life. SFP powder was suspended in 2 ml of milk 
replacer (application with a sterile syringe). Sucrosomial ferric pyrophosphate (SFP) 
represents an innovative oral iron-containing carrier in which ferric pyrophosphate 
is protected by a phospholipid bilayer membrane mainly from sunflower lecithin 
and sucrester matrix (Gómez-Ramírez et al., 2018). Feed intake was calculated as 
the intake per litter divided by the number of piglets in the litter. Weighed Prestarter 
was applied to play-feeder® troughs (Middelkoop et al., 2019). When the piglet lost 
interest in fodder, the remaining Prestarter was weighed. Average total Fe intake 
from creep feed/piglet (mg) has been calculated. Blood was drawn on day 28 after 
birth in both experimental groups by venipuncture of the jugular vein (Vena jugularis 
externa) into tubes coated with heparin as an anticoagulant. The blood samples were 
centrifuged (1200 x g, 10 min, 4°C) to separate the plasma. Plasma samples were 
immediately aliquoted and stored at –80°C. All experimental piglets were euthanized 
by the intracardiac injection of 0.5 mL/kg b.w. of Morbital (133.3 mg/mL of sodium 
pentobarbital + 26.7 mg/mL of pentobarbital, Biowet, Puławy, Poland). Sow’s milk 
was collected at day 21 of lactation. Tissue samples were collected, rinsed with PBS 
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(phosphate buffered saline) and then stored at –80°C until they were used for bio-
chemical analyses.


































bProduct formed during the production of isoglucose; crude protein 17,4%, Ether extract 3,85%, Crude 
fibre.7,48%, Crude ash 5,26%.
cPalm fat combined with lecithin. 
dPremix provided the following per kg of diets: Na: 0.28 g, Ca: 2.15 g, P: 0.7 g, Mg: 0.1 g, Lysine: 0.2 g, Fe: 
37 mg, Mn: 30 mg, I: 0.75 mg, Zn: 15 mg, Cu: 2.55 mg, Co: 0.1 mg, Se: 0.1 mg, Methionine: 50 mg, Threonine: 
90 mg, Tryptophan: 15 mg, Histidine: 17 mg, Vitamin A: 10000 IU, Vitamin D3: 1000 IU, Vitamin E: 20 mg, 
Vitamin K3: 1.5 mg, Vitamin B1: 0.3 mg, Vitamin B2: 0.8 mg, Vitamin B6: 1.0 mg, Vitamin B12: 10 µg, Niacin: 
5 mg, Folic acid: 0.5 mg, Biotin: 20 µg, Nicotinic acid: 6.5 mg, Pantothenic acid: 8 mg, Choline: 25 mg. 
eBonvital, lactic acid bacteria – Enterococcus faecium (DSM 7134, 4b1841), 1 x 1010 CFU/g (SCHAUMANN 
Agri International GmbH).
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RBCc (x 1012/L) 5.89 6.05 0.207 0.714
HGBd (g/dL) 8.90 8.80 0.381 0.517
HCTe (fraction) 0.20 0.26.1 1.827 0.535
MCVf (fL) 48.85 41.08 1.971 0.245
RDWg (%) 37.28 36.30 2.384 0.832
MCHh (pg) 14.40 13.54 0.531 0.451
Values are expressed as the mean ± SEM (nine male piglets per treatment). aIron dextran.  bSucrosomial 
ferric pyrophosphate. Blood cell indices were determined for piglets from each group on day 28 after birth. 
cRed blood cell count (× 106/µL). dHemoglobin concentration (g/dL). eHematocrit value (%). fMean corpuscular 
volume (fL). gRed cell distribution width (%). hMean cell hemoglobin (pg). 





Initial BW (kg) 1.89 2.02 0.056 0.971
Final BW  (kg) 7.16 7.14 0.210 0.957
Creep feed intake (g/day/piglet) 32.66 33.92 1.270 0.584
ADGc (g) 194.97 189.46 7.780 0.947
F:G ratiod (kg/kg) 0.16 0.17 0.009 0.949
Sow’s milk Fe (µg/g) 0.33 0.34 0.090 0.990
Values are expressed as the mean ± SEM (nine male piglets per treatment).  aIron dextran.  bSucrosomial 
ferric pyrophosphate.  cAverage daily gain in piglets during the period between days 1 and 28 after birth (g). 
dCreep feed to gain ratio.
Measurement of red blood cell indices and plasma iron level 
Hematological indices were determined using an automated ADVIA 2010 ana-
lyzer (Siemens, Munich, Germany). The plasma iron concentration was determined 
by colorimetric measurement of an iron-chromazurol complex according to the man-
ufacturer’s protocol (Alpha Diagnostic, Poland).
Measurement of 8-isoprostane level
Levels of 8-isoprostane, an oxidative stress marker were measured in plasma, 
spleen and liver according to the manufacturer’s protocol (8 isoprostane ELISA 
Kit (ab175819), Cambridge Biomedical Campus, UK) (Rajendran et al., 2019; Sta- 
rzyński et al., 2017).
Measurement of iron content and distribution in tissues
The non-heme iron contents of liver, spleen, kidney, heart, bone marrow and 
brain (100 mg), as well as milk samples (200 µl) were determined by acid digestion 
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of the samples at 100°C for 10 minutes, followed by colorimetric measurement of 
the absorbance of the iron-ferrozine complex at 560 nm (Beckman DU®-68 Spec-
trophotometer, CA, USA) as described previously (Torrance and Bothwell, 1980).
The heme content of formic acid-solubilized tissues was determined spectro-
photometrically at 398 nm (Beckman DU®-68 Spectrophotometer, CA, USA) us-
ing hemin standards prepared in formic acid and a molar absorption coefficient of 
1.5×105 M−1 cm−1 (Motterlini et al., 1995). Non-heme hepatic, splenic and bone mar-
row iron deposits were analyzed using the Accustain Iron Deposition Kit (Sigma Al-
drich, St. Louis, MO, USA). Briefly, liver and spleen samples excised immediately 
after sacrifice of piglets were fixed in Bouin’s solution for 24 h, then stored in 70% 
ethanol. After embedding in paraffin, the samples were cut into 7-μm sections using 
a microtome (Reichert-Jung, 2030; Nussloch, Germany). The sections were placed 
on a slide, deparaffinized and incubated with Perls’ Prussian Blue solution for 30 
minutes. Slides were counterstained with pararosaniline solution for 2 minutes and 
examined with a standard compound light microscope (Olympus, type CH2, Tokyo, 
Japan). The same procedure of staining with Prussian Blue was performed using 
bone marrow smears prepared from piglets. 
Blood plasma hepcidin-25 quantification
Hepcidin-25 measurements were performed as described previously for porcine 
plasma samples (Starzyński et al., 2013; Staroń et al., 2015) by a combination of weak 
cation exchange chromatography and time-of-flight mass spectrometry (WCX-TOF 
MS) using a stable hepcidin-25+40 isotope as internal standard for quantification. 
Peptide spectra were generated on a Microflex LT matrix-enhanced laser desorption/
ionisation TOF MS platform (Bruker Daltonics, Billerica, MA, USA). Hepcidin-25 
concentrations were expressed as nmol/L (nM). The lower limit of quantification of 
this method was 0.5 nM. The concentration of pig hepcidin-25 was calculated by 
comparing its mass peak height with that of the internal standard (Laarakkers et al., 
2013).
Statistical analysis
Data normality tests including the Shapiro-Wilk were performed. Results were 
statistically analyzed with Student’s t-test for normal distributed data or Mann-Whit-
ney test for non normal distributed data using GraphPad Prism version 8.0.1 for 
Windows (GraphPad Software, USA). P≤0.05, was considered significant. For the 
statistical analysis, each individual animal (n = 18) was considered as the experimen-
tal unit. Data are presented as mean values ± SEM. All measurements were made in 
two technical replicates.
Results
Red blood cell indices in piglets supplemented with FeDex and SFP
Oral supplementation of piglets with SFP (daily dose of 6 mg Fe) from day 5 
after birth up to weaning resulted in maintenance of values of red blood cell indices 
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of 28-day-old animals at physiological levels (Table 1). Importantly, hemoglobin 
concentration in these piglets (8.8±1.64 g/dL) was above the threshold value for 
anemia in pigs, i.e. 8 g/dL (Egeli and Framstad, 1998). In piglets receiving SFP, val-
ues of all hematological parameters were similar (showed no statistically significant 
differences) to those evaluated in animals given parenteral injection with FeDex, i.e. 
supplementation considered as highly efficient in preventing the occurrence of IDA 
and commonly used in pig rearing (Egeli and Framstad, 1999).
Importantly for pig farming and future fattening, feed intake was measured in 
both groups of piglets and showed no statistically siginificant differences (Table 
2). All growth performance parameters (Table 2) including daily body weight gain 
(from the 1st to the 28th day after birth), initial and final body weight and tissue 
weight (Table 2) of 28-day-old piglets receiving SFP per os were similar to those of 
animals given FeDex injections. Iron content in sow’s milk were similar (Table 2) 
and very low compared with creep feed offered to piglets during experiment (Sup-
plementary Table 1).
Blood plasma iron levels and tissue iron content and distribution in piglets 
supplemented with FeDex and SFP
To compare iron status of piglets from both experimental groups, we performed 
a comprehensive analysis of iron content in their tissues including the measurement 
of iron concentration in blood plasma, non-heme and heme iron content in liver, 
spleen, kidney, heart and brain (Table 4). Considering that liver, spleen and bone mar-
row are key organs for maintaining systemic iron balance, in addition, we analyzed 
the distribution of non-heme iron deposits in these tissues by staining with Perls’ 
Prussian Blue (Figure 1). We found that plasma iron levels in piglets supplemented 
with SFP were almost 2-fold higher compared with FeDex-treated animals (P<0.05) 
(Table 4), which attests to high nutritional bioavailability of SFP-derived iron and 
denotes adequate iron provision for piglets erythropoietic demand. In contrast to 
FeDex-derived iron, iron absorbed from oral supplement is not preferentially stored 
in the liver as evaluated by biochemical analysis of non-heme (Table 4) and histo-
logical analysis of iron deposit (Figure 1). Interestingly, supplementation of piglets 
with SFP resulted in significantly lower non-heme iron loading of the bone marrow 
compared to piglets receiving FeDex (P<0.05) (Figure 1). However, using Prussian 
Blue staining of bone marrow smears we failed to detect any iron deposits in samples 
from both SFP and FeDex supplemented piglets (Figure 1). In other tissues analyzed 
for iron content such as spleen, heart, brain, and kidney we detected no significant 
differences in non-heme iron level between SFP- and FeDex-supplemented animals 
(Table 4). Regarding tissue heme iron, its levels, regardless of the tissue, did not dif-
fer between piglets from two experimental groups (Table 3). 
Blood plasma and hepatic 8-isoprostane levels in piglets supplemented with 
FeDex and SFP
Application of supplemental iron to suckling piglets raises questions about the 
toxic effects of exposure to high iron levels at an early age. Considering that excess 
iron induces reactive oxygen species, we determined in 28-day-old piglets from both 
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experimental groups blood plasma and hepatic levels of 8-isoprostane, a biomarker 
providing a reliable measure of oxidative stress (Tsikas and Suchy, 2016). We found 
that in plasma of SFP-supplemented piglets, 8-isoprostane level was only half that 
measured in FeDex-treated animals (Table 4). In the liver of piglets receiving per os 
SFP we also observed decreased 8-isoprostane concentration, although this decline 
was not statistically significant. We did not observe a decrease in 8-isoprostane level 
in the spleen (Table 4).
Table 3. Comparison of different tissues weight in piglets supplemented with FeDexa and SFPb
Tissues 




Liver 2.72 2.86 0.180 0.579
Kidney 0.30 0.38 0.025 0.106
Spleen 0.27 0.27 0.012 0.972
Tissues weight are calculated on 100 g of body weight. Values are expressed as the mean ± SEM (nine male 
piglets per treatment). aIron dextran. bSucrosomial ferric pyrophosphate.
Table 4. Comparison of the tissular non-heme and heme iron content and 8-isoprostane levels in piglets 





Non heme iron levelc
(mg Fe/kg of wet tissue)
liver 116.55 29.50 14.110 0.001
spleen 55.66 76.44 7.951 0.205
kidney 21.00 21.60 4.160 0.868
heart 35.44 46.88 4.330 0.545
brain 9.60 8.80 3.010 0.879
bone marrow 9.20 4.00 1.110 0.008
Heme iron leveld
(mg Fe/kg of wet tissue)
liver 8.66 10.00 0.612 0.300
spleen 30.33 31.66 1.856 0.609
kidney 8.33 11.33 1.160 0.214
heart 8.66 11.16 1.077 0.060
brain 3.66 3.33 0.420 0.580
8-isoprostane levele (pg/ml) plasma 63.33 39.33 6.600 0.052
liver 765.66 613.83 58.153 0.090
spleen 28.67 30.19 1.976 0.723
Plasma iron level (µmol/L) 7.0857 9.3563 1.4128 0.043
Values are expressed as the means ± SEM for tissue samples obtained from pigs of each group (nine male 
piglets per treatment).
aIron dextran. bSucrosomial ferric pyrophosphate. cMeasured in following tissues: plasma, liver, spleen, 
kidney, heart, brain, bone marrow (mg Fe/kg of wet tissue). dMeasured in following tissues: liver, spleen, kidney, 
heart, brain (mg Fe/kg of wet tissue). eOxidative stress biomarker level was measured in plasma, liver and spleen 
(pg/ml).
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Figure 1. Comparison of iron deposits in spleen, bone marrow and liver in piglets supplemented with 
FeDexa and SFPb. Histological examination of iron loading in liver, spleen and bone marrow. Non-heme 
iron deposits were detected by staining with Perl’s Prussian Blue (blue stain) exclusively in Kupffer 
cells of piglets supplemented with FeDex (indicated by arrow heads). aIron dextran. bSucrosomial ferric 
pyrophosphate
Concentration of hepcidin-25 in the blood plasma of piglets supplemented 
with FeDex and SFP
Analysis of hepcidin level is helpful for guiding safe iron supplementation in pig-
lets. Here, we found that the concentration of hepcidin-25 in heparin-treated plasma 
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of piglets supplemented orally with SFP and parenterally with FeDex was not detect-
able in any of the samples (below the lower limit of detection, i.e. 0.5 nM). 
Discussion
In most mammals reserves of iron accumulated in the liver during gestation are 
primary source of this microelement in early postnatal life. However, in piglets he-
patic iron stores are relatively low and are rapidly exhausted during few days after 
birth (Peters and Mahan, 2008; Lipiński et al., 2010). Our previous data indicated 
that between day 1 and 3 postpartum in the Polish Landrace piglets iron content in the 
liver is drastically decreased to a barely detectable level (Lipiński et al., 2010). For 
this reason, exogenous iron fortification is crucial to prevent and treat iron deficiency 
in piglets. Intramuscular bolus injection of high amounts of iron in the form of Fe-
Dex to piglets, has emerged as an efficient technique to counteracting iron deficiency 
in pig breeding (Egeli and Framstad, 1999; Svoboda and Drabek, 2005; Szudzik et 
al., 2018). Interestingly, dietary supplements are usually much less effective (Egeli 
and Framstad, 1998; Szabo and Blikei, 2002; Svoboda and Píštková, 2018), unless 
iron is given in excessive (grams) quantities (Maes et al., 2011).
Iron absorption is a tightly regulated process, in which several iron transporters, 
oxidoreductases, and regulatory proteins act in concert to transfer adequate amount 
of dietary iron successively across the apical and basolateral membrane of duodenal 
enterocytes (Gulec et al., 2014). Poor responsiveness of suckling piglets during the 
neonatal period to orally administered iron salts and chelates is caused by impaired 
molecular mechanisms of iron absorption, i.e. very low expression of the main iron 
transporters in the duodenum (Lipiński et al., 2010). It seems that immaturity of 
molecular absorption machinery is a common developmental insufficiency in mam-
malian neonates as demonstrated in mice, rats and humans (reviewed in Lipiński 
et al., 2013). Nevertheless, the oral route of iron administration to piglets remains 
potentially an attractive procedure as it is noninvasive and enables accurate, gradual 
iron dosing during consecutive days of supplementation.
Liposomes (small vesicles enclosed by a lipid bilayer membrane) are now well 
recognized and widely used delivery carriers for drugs that can reduce systemic tox-
icity and increase drug delivery to the target sites in the body (Alavi et al., 2017). 
Importantly for this study, iron compounds encapsulated in liposomes have been 
successfully used to relieve the iron deficiency in various animal models (Zimmer-
mann, 2004). Here, we made an attempt to verify efficacy of SFP, liposomal iron 
preparation to rescue piglets from neonatal IDA. A strong indication for using SFP in 
the treatment of neonatal IDA in pig model was that its liposomal formulation allows 
transfer of iron (III) pyrophosphate encapsulated in liposomes across the duodenal 
barrier independently of established molecular pathways of iron absorption (Rodri-
guez et al., 2019; Pisani et al., 2015; Mazgaj et al., 2020). Furthermore, sucrose ester 
has the dual function of protecting the iron from stomach acid while interacting 
with the absorptive enterocytes. Preventive/curative effect of piglets supplementa-
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tion with SFP, was evaluated in comparison with the parenteral treatment of piglets 
with FeDex, a procedure with proven efficacy which is widely used in pig rearing 
(Egeli et al., 1998). In both groups of animals all analyzed RBC indices were similar 
and perfectly within the physiological range established for this age group of pigs 
(Egeli and Framstad, 1998). RBC count was insignificantly higher in piglets given 
SFP. Importantly, physiological RBC status of piglets receiving SFP was accompa-
nied by the normal growth performance as their body weight gain during the first 4 
weeks of life met the growth standards for the Polish Landrace breed and was higher 
than in anemic piglets. Our results prove that the amount and bioavailability of iron 
provided with SFP is adequate for meeting erythropoietic needs of suckling piglets. 
It is worth noting that the appearance of first IDA symptoms is usually preceded 
by the deterioration of systemic iron status. It often happens that while RBC indi-
ces remain within standards, hepatic iron stores decline. Therefore, we evaluated 
body iron content of piglets supplemented with SFP and found that these animals 
are sufficiently but not excessively replenished with this microelement, compared 
with FeDex-treated animals. Firstly, we found elevated iron level in blood plasma, 
which is a source of iron for erythropoiesis as it is known that diferric transferrin in 
the blood plasma is the major molecule providing iron for erythroid heme synthesis 
(Papanikolaou and Pantopoulos, 2017). Secondly, higher (but not significant) iron 
content detected in the spleen may reflect its contribution to erythropoietic activity. 
Accordingly, spleen is one of the extramarrow soft tissues that produce red blood 
cells (Orphanidou-Vlachou et al., 2014). Lower hepatic iron content in piglets sup-
plemented with SFP compared with those given FeDex may be due to the fact that 
after intramuscular injection of FeDex to animals, it enters the reticuloendothelial 
cells in the liver through lymphatic circulation and thus contributes to the exces-
sive iron accumulation in this tissue (Geisser et al., 1992). Indeed, in our studies 
(Lipiński et al., 2010; Staroń et al., 2015; Starzyński et al., 2013; present study) we 
constantly observed increased deposits of non-heme iron in hepatic macrophages 
(Browicz-Kupffer cells) after supplementation of piglets with FeDex. Saving reticu-
loendothelial macrophages from iron overload may be an advantage of SFP-based 
supplementation as high iron level in hepatic macrophages may contribute to the in-
duction of hepcidin expression (Rausa et al., 2015), a peptide that inhibits absorption 
of inorganic iron through canonical molecular mechanisms (Lipiński et al., 2010; 
Staroń et al., 2015). Hepcidin is an iron-regulatory hormone synthesized mainly by 
hepatocytes and secreted into the circulation as a 25 aa peptide. It acts as a negative 
regulator of iron absorption from the duodenum and iron release from macrophages 
recycling old red blood cells and thus adjusts iron supplies to body as per  iron re-
quirements (Muckenthaler et al., 2017). Animals supplemented with SFP showed no 
evidence of increased blood plasma hepcidin concentration, which was below the 
lower limit of detection, i.e. 0.5 nM. The expression of hepcidin is induced transcrip-
tionally mainly in response to iron. There is experimental evidence that both hepatic 
iron loading (Pigeon et al., 2001) and high saturation of plasma transferrin with 
iron (Lin et al., 2007) stimulate hepcidin synthesis. We hypothesize that in piglets 
supplemented with SFP neither transferrin saturation nor hepatic iron level reached 
a threshold that could have induced hepcidin. Interestingly, we also found a very low 
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blood plasma hepcidin level (below 0.5 nM) in FeDex-treated animals. By contrast, 
hepcidin-25 concentration was strongly elevated in the plasma of 28-day-old piglets 
subjected to the procedure of 2-fold FeDex injection on days 3 and 21 after birth used 
in our previous studies (Starzyński et al., 2013; Staroń et al., 2015). 
According to the double-edge sword nature of iron, this biometal, apart from be-
ing an essential micronutrient, is potentially toxic due to its redox properties leading 
to the generation of highly toxic reactive oxygen species. In this context, evaluation 
of any iron supplementation procedure must involve an assessment of its toxic ef-
fects. Administration of iron to piglets in the form of FeDex carries a risk of over-
supplementation. During this procedure, piglets usually receive in a bolus injection 
an amount of iron, which exceeds 4–5 times the total content of this element in their 
body. Consequently, only a part of supplemental iron may be used for physiological 
purposes. The remaining part may be potentially toxic. We have previously demon-
strated that supplementation of piglets with FeDex induces oxidative damage to DNA 
in the liver (Lipiński et al., 2010). In this study, despite using lower dose of FeDex, 
piglets receiving this treatment showed the plasma concentration of 8-ispoprostane, 
a popular lipid peroxidation marker (Tsikas and Suchy, 2016) at level almost twice 
as high as animals supplemented with SFP. As 8-isoprostane found in blood plasma 
originates from lipid membranes in any tissue of the piglet’s body, its plasma levels 
furnishes a systematic and integrated evaluation of oxidative stress in the whole or-
ganism. Our results indicate considerably reduced levels of oxidative stress in piglets 
fed with SFP compared to animals injected with FeDex. It is noteworthy that the 
total amount of supplemental iron given per piglet from each experimental group is 
higher in FeDex group than in SFP group (~200 versus 138 mg). Although we can-
not calculate the exact amount of iron absorbed by piglets from SFP, our observation 
shows that the content of iron in feces of piglets from both group is similar (FeDex 
0.645 vs. SFP 0.747 mg/kg feces). This suggests that the major part of iron applied 
orally with SFP is absorbed by piglets. Moreover, our time consuming procedure of 
individual SFP application to animals may be justified by the fact that we wanted to 
strictly control the amount of supplemental iron. Such control is indispensable when 
testing for the first time a new iron supplement. Previously, we have tested the effi-
cacy of heme iron in prophylaxis of IDA in piglets by adding powdered hemoglobin 
directly to the feed. We hypothesize that conducting a large-scale experiment using 
SFP will reveal the utility of this supplement to prevent IDA in pigs rearing/farming.
Conclusion
We conclude that oral supplementation of suckling piglets with sucrosomial fer-
ric pyrophosphate during a period of 23 consecutive days, resulted in similar thera-
peutic effect and caused decreased toxicity of supplemental iron compared to the 
procedure of iron dextran injection on day 3 after birth. In this context, supplementa-
tion with sucrosomial ferric pyrophosphate appears a promising procedure that can 
be applied for the correction of iron deficiency anemia in suckling piglets. However, 
the details about molecular mechanisms of sucrosomial ferric pyrophosphate absorp-
tion in piglets after per os application remain to be elucidated. Appropriate studies in 
this direction are currently being carried out in our laboratory.
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